| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba710e7aaa56d8ab15a910fcd3dc5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f9ea6621079cc7a2f96c3fd454e2a86 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4417ec5a2a411625b1ed3882f97e381c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ccd908cd524d31fa885beaf5cb28a1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba97e4a101a2a50a4f44fda41a1f2b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93856049afbcebb28b500cd7da2a6185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72988abd2818e84699d93f52987e8557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b9a8edc5905a91fcf23b3bc7399e44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ee208c18afa092d7335b7e99eb85ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d1961153d571d59adbcdede1e517a9 |
| publicationDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019191232-A3 |
| titleOfInvention |
Nucleic acid molecules for pseudouridylation |
| abstract |
The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme. |
| priorityDate |
2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |